Compare VVOS & CWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VVOS | CWD |
|---|---|---|
| Founded | 2016 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.7M | 10.0M |
| IPO Year | 2020 | 2022 |
| Metric | VVOS | CWD |
|---|---|---|
| Price | $0.51 | $0.79 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $2.75 | N/A |
| AVG Volume (30 Days) | ★ 3.6M | 79.9K |
| Earning Date | 04-15-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 6.76 | N/A |
| EPS | N/A | N/A |
| Revenue | $17,443,000.00 | ★ $20,097,000.00 |
| Revenue This Year | $69.66 | N/A |
| Revenue Next Year | $48.38 | $19.17 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 16.05 | N/A |
| 52 Week Low | $0.49 | $0.73 |
| 52 Week High | $7.40 | $46.21 |
| Indicator | VVOS | CWD |
|---|---|---|
| Relative Strength Index (RSI) | 33.65 | 36.64 |
| Support Level | N/A | N/A |
| Resistance Level | $0.76 | $1.13 |
| Average True Range (ATR) | 0.14 | 0.07 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 5.98 | 16.75 |
Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.
CaliberCos Inc is an asset management firm whose primary goal is to enhance the wealth of investors seeking to make investments in middle-market assets. The company's funds include investment vehicles focused on real estate, private equity, and debt facilities. The company earns asset management fees calculated as a percentage of managed capital in funds and offerings. The company markets services through direct sales to private investors, wholesaling to investment advisers, direct sales to family offices and institutions and through in-house client services. The company operates into three reportable segments: Fund Management, Development, and Brokerage. The majority of revenue is derived from the fund management fees segment.